Breast Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 years or older.
- People who are willing and able to take part and provide blood, urine, and saliva samples, as well as basic personal information such as age, sex, race/ethnicity, and body weight category (BMI).
- People who are able to sign a written consent form agreeing to take part and to allow their biological samples to be used for research.
- People whose background characteristics (race, ethnicity, and BMI) are broadly comparable to other participants in the trial.
- For the cancer group only: People who have received a confirmed cancer diagnosis within the 90 days before sample collection, supported by a biopsy and imaging to determine the stage of the cancer, and who have not had any cancer treatment at the time of collection or in the previous 3 years.
- For the cancer-free (healthy) group only: People who have had no cancer diagnosis or cancer treatment in the previous 3 years, are not currently being investigated for suspected cancer, and do not have any clinical signs that a benign or uncertain tumor has progressed or become cancerous.
- For the tumor-burden monitoring sub-study only: People with a biopsy-confirmed cancer diagnosis whose general physical functioning meets a specific performance threshold (confirm with trial site).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who do not meet the general or group-specific criteria listed above.
- People who are currently pregnant.
- People who have had an organ transplant.
- People who are currently taking or have taken certain medications that affect DNA chemistry (such as azacitidine or decitabine) or cytotoxic (cell-destroying) drugs, including those taken for autoimmune or inflammatory conditions.
- People who have had, or are currently receiving, any form of cancer treatment beyond a diagnostic biopsy — including surgery for cancer, chemotherapy, targeted therapy, immunotherapy (including cancer vaccines), hormonal therapy, or radiotherapy.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +573016348173
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity of the Methylscape test for cancer-signal detection, as assessed against histopathological confirmation as the reference standard; Specificity of the Methylscape test for cancer-signal detection, as assessed against absence of cancer confirmed by medical-record review and 12-month follow-up
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.